Insider Trading activities of Recro Pharma, Inc. insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Recro Pharma, Inc. since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Recro Pharma, Inc. since year 2005. Table 2 shows the detailed insider transactions of Recro Pharma, Inc. since 2005. The reporting company's ticker symbol is REPH. The reporting company's CIK number is 1588972.
The total value of stock buying since 2005 is $15,172,542.
The total value of stock sales since 2005 is $11,170,209.
The total value of stock option exercises since 2005 is $0.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Recro Pharma, Inc. (REPH).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2017-09 0 $0 0 $0 77,100 $0
2017-06 0 $0 173,315 $1,150,234 0 $0
2017-05 0 $0 971,937 $7,318,708 0 $0
2017-03 0 $0 60,000 $480,238 0 $0
2017-02 0 $0 40,000 $312,444 0 $0
2016-12 659,300 $3,961,019 0 $0 0 $0
2016-08 390,000 $2,925,000 0 $0 11,100 $0
2016-05 12,390 $97,966 110,000 $708,517 0 $0
2015-11 0 $0 133,324 $1,200,068 0 $0
2015-07 646,553 $7,500,014 0 $0 0 $0
2015-06 6,500 $57,136 0 $0 0 $0
2014-12 241,338 $603,345 0 $0 0 $0
2014-05 4,200 $28,062 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Recro Pharma, Inc. insiders (REPH)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2017-09-28 Graff Fred (Chief Commercial Officer) Option Ex 2,000 .00 0
2017-09-28 Mccallum Stewart (Chief Medical Officer) Option Ex 15,000 .00 0
2017-09-28 Mack Randall (Senior VP, Development) Option Ex 15,000 .00 0
2017-09-28 Myers Diane (Director) Option Ex 8,000 .00 0
2017-09-28 Celano Michael (Chief Financial Officer) Option Ex 6,000 .00 0
2017-09-28 Henwood Geraldine (President and CEO) Option Ex 31,100 .00 0
2017-06-14 Deerfield Special Situations Fund, L.p. Sale 68,000 6.25 425,000
2017-06-13 Deerfield Special Situations Fund, L.p. Sale 32,447 6.59 213,825
2017-06-12 Deerfield Special Situations Fund, L.p. Sale 10,000 6.74 67,400
2017-06-08 Deerfield Special Situations Fund, L.p. Sale 17,245 6.99 120,542
2017-06-07 Deerfield Special Situations Fund, L.p. Sale 45,623 7.09 323,467
2017-05-12 Stonepine Capital Management, Llc Sale 510,000 7.40 3,774,000
2017-05-11 Stonepine Capital Management, Llc Sale 9,000 7.96 71,685
2017-05-10 Stonepine Capital Management, Llc Sale 7,500 7.77 58,297
2017-05-09 Stonepine Capital Management, Llc Sale 228,129 7.63 1,741,764
2017-05-04 Stonepine Capital Management, Llc Sale 201,160 7.69 1,547,121
2017-05-03 Stonepine Capital Management, Llc Sale 16,148 7.79 125,841
2017-03-16 Scp Vitalife Partners (israel) Ii, L.p. (10% Owner) Sale 3,170 7.93 25,125
2017-03-16 Scp Vitalife Partners Ii Lp (10% Owner) Sale 9,488 7.93 75,201
2017-03-15 Scp Vitalife Partners (israel) Ii, L.p. (10% Owner) Sale 6,399 8.01 51,268
2017-03-15 Scp Vitalife Partners Ii Lp (10% Owner) Sale 19,161 8.01 153,517
2017-03-14 Scp Vitalife Partners (israel) Ii, L.p. (10% Owner) Sale 5,454 8.04 43,850
2017-03-14 Scp Vitalife Partners Ii Lp (10% Owner) Sale 16,328 8.04 131,277
2017-02-17 Scp Vitalife Partners (israel) Ii, L.p. (10% Owner) Sale 3,334 7.59 25,311
2017-02-17 Scp Vitalife Partners Ii Lp (10% Owner) Sale 9,983 7.59 75,790
2017-02-16 Scp Vitalife Partners (israel) Ii, L.p. (10% Owner) Sale 1,100 7.86 8,642
2017-02-16 Scp Vitalife Partners Ii Lp (10% Owner) Sale 3,293 7.86 25,873
2017-02-15 Scp Vitalife Partners (israel) Ii, L.p. (10% Owner) Sale 2,164 7.88 17,052
2017-02-15 Scp Vitalife Partners Ii Lp (10% Owner) Sale 6,479 7.88 51,054
2017-02-14 Scp Vitalife Partners (israel) Ii, L.p. (10% Owner) Sale 766 7.96 6,094
2017-02-14 Scp Vitalife Partners Ii Lp (10% Owner) Sale 2,293 7.96 18,243
2017-02-13 Scp Vitalife Partners (israel) Ii, L.p. (10% Owner) Sale 2,651 7.97 21,128
2017-02-13 Scp Vitalife Partners Ii Lp (10% Owner) Sale 7,937 7.97 63,257
2016-12-16 Weisman Wayne (Director) Buy 3,000 6.57 19,710
2016-12-16 Flynn Karen (Director) Buy 800 6.71 5,364
2016-12-15 Weisman Wayne (Director) Buy 4,000 6.53 26,120
2016-12-15 Altomari Alfred (Director) Buy 1,500 6.55 9,825
2016-12-13 Kotler Kevin Buy 650,000 6.00 3,900,000
2016-08-16 Kotler Kevin Buy 390,000 7.50 2,925,000
2016-08-01 Mack Randall (Senior VP, Development) Option Ex 6,100 .00 0
2016-08-01 Myers Diane (Senior VP-Reg/Quality) Option Ex 2,500 .00 0
2016-08-01 Nichols Donna (CAO/Controller) Option Ex 2,500 .00 0
2016-05-31 Graff Fred (Chief Commercial Officer) Buy 8,000 8.46 67,704
2016-05-31 Mccallum Stewart (Chief Medical Officer) Buy 250 8.50 2,125
2016-05-26 Mccallum Stewart (Chief Medical Officer) Buy 1,000 8.15 8,150
2016-05-23 Scp Vitalife Partners (israel) Ii, L.p. (10% Owner) Sale 2,503 6.30 15,768
2016-05-23 Mack Randall (Senior VP, Development) Buy 2,000 6.30 12,600
2016-05-23 Scp Vitalife Partners Ii Lp (10% Owner) Sale 7,497 6.30 47,231
2016-05-20 Scp Vitalife Partners (israel) Ii, L.p. (10% Owner) Sale 5,008 6.46 32,326
2016-05-20 Weisman Wayne (Director) Sale 20,000 6.46 129,100
2016-05-20 Scp Vitalife Partners Ii Lp (10% Owner) Sale 14,992 6.46 96,773
2016-05-20 Ludomirski Abraham (Director) Sale 20,000 6.46 129,100
2016-05-20 Churchill Winston J (Director) Sale 20,000 6.46 129,100
2016-05-19 Scp Vitalife Partners (israel) Ii, L.p. (10% Owner) Sale 1,252 6.46 8,082
2016-05-19 Weisman Wayne (Director) Sale 5,000 6.46 32,280
2016-05-19 Nichols Donna (CAO/Controller) Buy 1,140 6.48 7,387
2016-05-19 Scp Vitalife Partners Ii Lp (10% Owner) Sale 3,748 6.46 24,197
2016-05-19 Ludomirski Abraham (Director) Sale 5,000 6.46 32,280
2016-05-19 Churchill Winston J (Director) Sale 5,000 6.46 32,280
2015-11-30 Scp Vitalife Partners (israel) Ii, L.p. (10% Owner) Sale 150 9.00 1,350
2015-11-30 Weisman Wayne (Director) Sale 600 9.00 5,400
2015-11-30 Scp Vitalife Partners Ii Lp (10% Owner) Sale 450 9.00 4,050
2015-11-30 Ludomirski Abraham (Director) Sale 600 9.00 5,400
2015-11-30 Churchill Winston J (Director) Sale 600 9.00 5,400
2015-11-27 Scp Vitalife Partners (israel) Ii, L.p. (10% Owner) Sale 2,250 9.00 20,252
2015-11-27 Weisman Wayne (Director) Sale 8,987 9.00 80,891
2015-11-27 Scp Vitalife Partners Ii Lp (10% Owner) Sale 6,737 9.00 60,639
2015-11-27 Ludomirski Abraham (Director) Sale 8,987 9.00 80,891
2015-11-27 Churchill Winston J (Director) Sale 8,987 9.00 80,891
2015-11-25 Scp Vitalife Partners (israel) Ii, L.p. (10% Owner) Sale 1,553 9.00 13,977
2015-11-25 Weisman Wayne (Director) Sale 6,201 9.00 55,809
2015-11-25 Scp Vitalife Partners Ii Lp (10% Owner) Sale 4,648 9.00 41,832
2015-11-25 Ludomirski Abraham (Director) Sale 6,201 9.00 55,809
2015-11-25 Churchill Winston J (Director) Sale 6,201 9.00 55,809
2015-11-24 Scp Vitalife Partners (israel) Ii, L.p. (10% Owner) Sale 691 9.01 6,223
2015-11-24 Weisman Wayne (Director) Sale 2,759 9.01 24,847
2015-11-24 Scp Vitalife Partners Ii Lp (10% Owner) Sale 2,068 9.01 18,624
2015-11-24 Ludomirski Abraham (Director) Sale 2,759 9.01 24,847
2015-11-24 Churchill Winston J (Director) Sale 2,759 9.01 24,847
2015-11-23 Scp Vitalife Partners (israel) Ii, L.p. (10% Owner) Sale 3,702 9.00 33,321
2015-11-23 Weisman Wayne (Director) Sale 14,784 9.00 133,070
2015-11-23 Scp Vitalife Partners Ii Lp (10% Owner) Sale 11,082 9.00 99,749
2015-11-23 Ludomirski Abraham (Director) Sale 14,784 9.00 133,070
2015-11-23 Churchill Winston J (Director) Sale 14,784 9.00 133,070
2015-07-07 Kotler Kevin Buy 646,553 11.60 7,500,014
2015-06-08 Henwood Geraldine (President and CEO) Buy 550 9.56 5,258
2015-06-05 Garner Charles (CFO and Chief Business Officer) Buy 2,000 8.50 17,000
2015-06-05 Henwood Geraldine (President and CEO) Buy 3,950 8.83 34,878
2014-12-02 Kotler Kevin Buy 241,338 2.50 603,345
2014-05-15 Garner Charles (CFO and Chief Business Officer) Buy 3,000 6.69 20,070
2014-05-15 Nichols Donna (CAO/Controller) Buy 1,200 6.66 7,992

Insider trading activities including stock purchases, stock sales, and option exercises of REPH listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Recro Pharma, Inc. (symbol REPH, CIK number 1588972) see the Securities and Exchange Commission (SEC) website.